Case studies in cannabis vaporization

Addiction Research and Theory

Volumn 18, Issue 3, 2010, Pages 243-249

  Earleywine, Mitch ^a   Van Dam, Nicholas T ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cannabis; Lung disease; Marijuana; Respiratory symptoms; Vaporizer

Indexed keywords

EID: 77951643725     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066350902974753     Document Type: Article

References (12)

1. Abrams D, Vizoso H, Shade S, Jay C, Kelly M. 2007. Vaporization as a smokeless cannabis delivery system: A pilot study. Clinical Pharmacology and Therapeutics 82:572-578. (Pubitemid 47622524)
2. American Psychiatric Association (APA). 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
3. Armeli S, Carney M, Tennen H, Affleck G, O'Neil T. 2000. Stress and alcohol use: A daily process examination of the stressor-vulnerability model. Journal of Personality and Social Psychology 78:979-994.
4. Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. 2007. Emphysema and secondary pneumothorax in young adults smoking cannabis. European Journal of Cardio-Thoracic Surgery 32:834-838. (Pubitemid 350052575)
5. Earleywine M, Smucker Barnwell S. 2007. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal 2007, 4:11. Available from: http://www.harmreductionjournal.com/content/4/1/11
6. Gieringer D, St Lauren TJ, Goodrich S. 2004. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. Journal of Cannabis Therapeutics 4:7-27. (Pubitemid 38528766)
7. Hazekamp A, Ruhaak R, Zuurman L, van Gerven J, Verpoorte R. 2006. Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Science 95:1308-1317. (Pubitemid 43874444)
8. Sobell LC, Sobell MB. 2000. Alcohol timeline followback. In: American Psychiatric Association, editor. Handbook of psychiatric measures. Washington, DC: American Psychiatric Association. pp 477-479.
9. Taylor DR, Fergusson DM, Milne BJ, Horwood LJ, Moffitt TE, Sears MR, Poulton R. 2002. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 97:1055-1061.
10. Volkova NB, Kodani A, Hilario D, Munyaradzi SM, Peterson MW. 2009. Spirometry utilization after hospitalization for patients with chronic obstructive pulmonary disease exacerbations. American Journal of Medical Quality 24:61-66.
11. Walden N, Earleywine M. 2008. How high? Quantity as a predictor of cannabis-related problems. Harm Reduction Journal, 5:20. Available from: http://www.harmreductionjournal.com/content/5/1/20
12. Yin RK. 1999. Enhancing the quality of case studies in health services research. Health Services Research 34:1209-1224.